Lytic therapy in vitreous haemorrhage

Trans Ophthalmol Soc U K (1962). 1974 Jul;94(2):583-6.
No abstract available

MeSH terms

  • Endopeptidases / therapeutic use*
  • Eye Diseases / drug therapy
  • Fibrinolysis
  • Hemorrhage / drug therapy*
  • Humans
  • Time Factors
  • Urokinase-Type Plasminogen Activator / administration & dosage
  • Urokinase-Type Plasminogen Activator / therapeutic use*
  • Visual Acuity
  • Vitreous Body*

Substances

  • Endopeptidases
  • Urokinase-Type Plasminogen Activator